Stem CellsBioengineeringPeer-reviewed journal article
Cell Barcoding Reveals Lineage-dependent Outcomes in hiPSC Cardiac Differentiation
Sogu SohniD, Daylin MorganiD, Cody J. CallahaniD, Katelyn Dockery, Amy BrockiD, Janet ZoldaniD
Abstract
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have potential applications in treating cardiovascular disease but are currently limited in their clinical translation. A primary limitation is the poor clinical scalability of hiPSC-CMs, with the heterogeneity of hiPSC cardiac differentiation significantly contributing to this limitation. We hypothesize that clinical scalability can be improved by tracking and controlling hiPSC clonal heterogeneity, a variable often overlooked in current differentiation approaches. "Fate priming", wherein clonal lineage identity determines differentiation fate, has been demonstrated in other stem cell differentiation pathways. We investigated fate priming in hiPSC cardiac differentiation using the ClonMapper cell barcoding platform to label, track, and isolate distinct hiPSC lineages from the same cell line. We show that certain hiPSC lineages preferentially differentiate into hiPSC-CMs or non-CMs. After isolating lineages with apparent fate priming, we found significant differences in cardiac differentiation outcomes between these single-clone populations and heterogeneous, multi-clone hiPSC populations. These findings indicate that lineage identity influences hiPSC cardiac differentiation outcomes. SIGNIFICANCE STATEMENTCardiovascular disease is a significant global health concern that can be addressed by engineering artificial tissues to develop new treatments for heart disease or to directly replace damaged heart tissue. Stem cells are a useful tool for engineering these tissues because of their ability to become cardiomyocytes. However, their clinical translation is limited by variability in the process of differentiating stem cells into cardiomyocytes. This article reports findings that show different lineages of genetically identical human induced pluripotent stem cells have different capacities for differentiating into cardiomyocytes, which may contribute to the variability observed.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 1
- FWCI
- 2.07
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Undergo Clonal Expansion In Vivo
D. El-Nachef, D. Bugg, … J. Davis·bioRxiv·Nov 20, 2019
- A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes
T. Grancharova, K. A. Gerbin, … R. N. Gunawardane·bioRxiv·Apr 22, 2021
- Early multi-omic signatures and machine learning models predict cardiomyocyte differentiation efficiency and enable robust hPSC differentiation to cardiomyocytes
Austin K. Feeney, Aaron D. Simmons, … Sean P. Palecek·bioRxiv·Jan 9, 2026
- Cell type determination for cardiac differentiation occurs soon after seeding of human induced pluripotent stem cells
Connie Jiang, Yogesh Goyal, … Arjun Raj·Genome biologyPeer-reviewed·Apr 5, 2022
- Combined Lineage Tracing and scRNA-seq Reveals Unexpected First Heart Field Predominance of Human iPSC Differentiation
Francisco X. Galdos, Carissa Lee, … Sean M. Wu·eLifePeer-reviewed·Jun 5, 2023
- Guided Differentiation of Pluripotent Stem Cells for Cardiac Cell Diversity
Erik M. McIntire, Kenneth Barr, … Yoav Gilad·bioRxiv·Jul 21, 2023